Carolyn Presley on the Implications of Screening on Lung Cancer Care

The first patients in a phase 1/2 trial have received a combination of HPN328, an immunotherapy, and Tecentriq for small cell lung cancer.

Lung cancer survivor Terri Conneran shares her story of creating a non-profit to help connect with fellow patients and survivors who have the KRAS biomarker.

When combined with Keytruda, the novel drug, NC318, proved to be safe and efficacious in treating advanced non-small cell lung cancer, research showed.

A man shares how reading the footnote of a CT scan looking for heart disease alerted him to a mass in his right lung, leading to an unexpected diagnosis of lung cancer.

The treatment combination of Imfinzi plus radiotherapy is “promising” for certain patients with NSCLC, according to preliminary findings from a trial.

Treatment with perioperative Imfinzi plus neoadjuvant chemotherapy may improve surgery outcomes for patients with resectable non-small cell lung cancer.